Efflux Pump Inhibitors: A Strategy to Combat P-Glycoprotein and the NorA Multidrug Resistance Pump

被引：47
|
作者：
Zhang, Ling [1 ]
Ma, Shutao [1 ]
机构：
[1] Shandong Univ, Sch Pharmaceut Sci, Dept Med Chem, Jinan 250012, Peoples R China
来源：
CHEMMEDCHEM | 2010年 / 5卷 / 06期
基金：
中国国家自然科学基金;
关键词：
cancer; inhibitors; multidrug resistance; NorA pump; P-glycoprotein; VITAMIN-E TPGS; STAPHYLOCOCCUS-AUREUS; DRUG-RESISTANCE; 2,4,5-TRISUBSTITUTED IMIDAZOLES; ORAL BIOAVAILABILITY; NONTOXIC MODULATORS; REVERSAL AGENTS; LEUKEMIA-CELLS; IN-VITRO; PHASE-I;
D O I：
10.1002/cmdc.201000006
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Multidrug resistance (MDR) is the cause of an ever-increasing number of problems in the treatment of cancers and bacterial infections. The active efflux of drugs contributes significantly to this phenomenon. This minireview summarizes recent advances in combating MDR, with particular emphasis on natural and synthetic efflux pump inhibitors of P-glycoprotein in resistant tumor cells and of the NorA MDR pump in Staphylococcus aureus.
引用
收藏
页码：811 / 822
页数：12
相关论文
共 50 条
  • [41] Designing potent inhibitors against the multidrug resistance P-glycoprotein
    Mahmud, Shafi
    Islam, Md. Jahirul
    Parves, Md. Rimon
    Khan, Md. Arif
    Tabussum, Lamiya
    Ahmed, Sinthyia
    Ali, Md. Ackas
    Fakayode, Sayo O.
    Halim, Mohammad A.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (19): : 9403 - 9415
  • [42] Expression and activity of P-glycoprotein efflux pump in lymphomonocytes of transplanted kidney subjects
    Conti, G
    Amore, A
    Turcato, S
    Ghisellini, L
    Cirina, P
    Roasio, L
    Ricotti, E
    Messina, M
    Segoloni, GP
    Coppo, R
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V158 - V158
  • [43] Efflux Pump Inhibitors: A Novel Approach to Combat Efflux-Mediated Drug Resistance in Bacteria
    Wang, Yinhu
    Venter, Henrietta
    Ma, Shutao
    CURRENT DRUG TARGETS, 2016, 17 (06) : 702 - 719
  • [44] P-GLYCOPROTEIN IS A CELLULAR EFFLUX PUMP OF LUMINAL CARCINOGEN IN NORMAL HUMAN INTESTINE
    PENNY, JI
    CAMPBELL, FC
    BRITISH JOURNAL OF SURGERY, 1994, 81 (12) : 1822 - 1822
  • [45] INHIBITION OF THE MULTIDRUG-RESISTANCE EFFLUX PUMP
    WIGLER, PW
    PATTERSON, FK
    BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1154 (02) : 173 - 181
  • [46] P-glycoprotein efflux pump expression and activity in Calu-3 cells
    Hamilton, KO
    Backstrom, G
    Yazdanian, MA
    Audus, KL
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 90 (05) : 647 - 658
  • [47] Identification of budesonide and prednisone as substrates of the intestinal drug efflux pump P-glycoprotein
    Dilger, K
    Schwab, M
    Fromm, MF
    INFLAMMATORY BOWEL DISEASES, 2004, 10 (05) : 578 - 583
  • [48] Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor
    Fox, Elizabeth
    Bates, Susan E.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (04) : 447 - 459
  • [49] Identification of Novel Inhibitors of P-glycoprotein Mediated Multidrug Resistance
    Follit, Courtney A.
    McCormick, James W.
    Nanayakkara, Amila K.
    Wise, John G.
    Vogel, Pia D.
    FASEB JOURNAL, 2017, 31
  • [50] In situ biochemical demonstration that P-glycoprotein is a drug efflux pump with broad specificity
    Chen, Y
    Simon, SM
    JOURNAL OF CELL BIOLOGY, 2000, 148 (05): : 863 - 870
12345